Roxane’s generic antidepressant receives FDA approval
COLUMBUS, Ohio The Food and Drug Administration has approved Roxane Labs’ generic version of an antidepressant, Roxane said Monday.
The FDA approved imipramine pamoate capsules in the 75-mg, 100-mg, 125-mg and 150-mg strengths. Roxane said it would begin shipping the drug immediately.
The drug is a generic version of Tyco Healthcare’s Tofranil-PM, which has sales of around $10.1 million a year, according to Roxane.
FDA approves Toprol XL generic
MORRISTOWN, N.J. The Food and Drug Administration has approved a generic version of a drug for treating heart disease made by Watson Pharmaceuticals, Watson announced Thursday.
The FDA approved Watson’s metoprolol succinate extended-release tablets in the 100-mg and 200-mg strengths. The drug is used to treat angina, heart failure and hypertension.
The tablets are a generic version of AstraZeneca’s Toprol XL, which had sales of $403 million during the 12-month period ended in February, according to IMS Health.
NCPA, partners launch Dispose My Meds campaign
ALEXANDRIA, Va. A group representing the nation’s independent pharmacists will be kicking off a campaign with Sharps Compliance and the Community Anti-Drug Coalitions of America to address ways consumers can safely dispose prescription medications.
The National Community Pharmacists Association said the Dispose My Meds campaign, an official Earth Day activity, will provide consumers with unprecedented options to safely and responsibly dispose of unused medications at hundreds of participating community pharmacies nationwide.
More than four billion prescriptions are written annually in the United States, according to estimates, and up to 40% of drugs dispensed outside of hospitals go unused, generating some 200 million pounds of pharmaceutical waste each year, NCPA said. Additionally, NCPA said, unused patient medications are a contributor to traces of pharmaceuticals being found in America’s drinking water and accidental poisonings, which have involved an 80% increase in U.S. deaths from accidental overdose of narcotics in a recent six-year period.
NCPA president Joe Harmison, in addition to Claude Dance, Sharps Compliance SVP sales and marketing, and Mark Elizabeth Elliott, Community Anti-Drug Coalitions of America VP communications, membership and IT, will host a conference call April 19 to discuss the initiative. For more information or to RSVP, please contact John Norton, NCPA, at 703-600-1174 or email@example.com.